95 related articles for article (PubMed ID: 15065160)
1. 1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification.
Lee MC; Pirzkall A; McKnight TR; Nelson SJ
J Magn Reson Imaging; 2004 Apr; 19(4):379-88. PubMed ID: 15065160
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
3. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
4. Long-term normal-appearing brain tissue monitoring after irradiation using proton magnetic resonance spectroscopy in vivo: statistical analysis of a large group of patients.
Matulewicz Ł; Sokół M; Michnik A; Wydmański J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):825-32. PubMed ID: 16949766
[TBL] [Abstract][Full Text] [Related]
5. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
6. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
8. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
[TBL] [Abstract][Full Text] [Related]
9. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
Qiu SJ; Zhang XL; Zhang Y; Jiang M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
[TBL] [Abstract][Full Text] [Related]
13. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
[TBL] [Abstract][Full Text] [Related]
14. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
16. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
17. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
20. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
